focus -WSS

focus

author：leisure time 2025-09-30 16:26:58 - browse：484

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Abortion pill Supreme Court ruling could impact entire drug industry

WSS

Study says nonprofit hospitals fall short in charity care spending

Will generative AI in health care meet the fate of IBM's Dr. Watson?

The Readout: Lenmeldy, GLP

Eyeing GLP

Decaf coffee targeted by food safety group under obscure FDA rule

H5N1 virus can be tracked in retail milk, scientists say

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Covid vaccine financial winners and losers, from Pfizer to Novavax

Virginia high school admissions case could be legal follow

States should stop sabotaging methadone treatment reform

Guidelines to prevent youth baseball injuries need more muscle

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Malaria cases in Florida and Texas: Here’s what you need to know

As a primary care physician, here's how I hope to partner with AI

Affirmative action in medical school literally saved lives

Digital health: a case of mistaken identity

explore

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Roche subsidiary Foundation Medicine opens new headquarters

Readout Newsletter: Merck, Vertex, and Viking updates

UnitedHealth argues against case alleging wrongful AI care denials

States should stop sabotaging methadone treatment reform

Readout Newsletter: Merck, Vertex, and Viking updates

hotspot

entertainment

hotspot

leisure time